About Pilot gene technology
Pilot gene technology is a company based in Hangzhou (China) founded in 2017. Pilot gene technology has raised $18.51 million across 1 funding round from investors including Share Capital. Pilot gene technology offers products and services including Digital PCR System and PCR Detection Kits.
- Headquarter Hangzhou, China
- SectorsHealthcare
- Website pilotgene.com
- Social LinkedIn
- Legal Name 领航基因科技（杭州）有限公司
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
- Total Equity Funding$18.51M (USD)
in 1 rounds
- Latest Funding Round$18.51M (USD), Series A
Jul 2021
- Investors
Associated legal entities of Pilot gene technology
Pilot gene technology operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Pilot gene technology
Pilot gene technology offers a comprehensive portfolio of products and services, including Digital PCR System and PCR Detection Kits.
Digital PCR systems are utilized for pathogen detection in clinical environments, where they are applied to analyze samples for infections
PCR detection kits are employed for rapid testing of conditions like bloodstream infections, where they are integrated into automated systems for efficient results
Funding Insights of Pilot gene technology
Pilot gene technology has successfully raised a total of $18.51M through 1 strategic funding round. The most recent funding activity was a Series A round of $18.51 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.51M
- Total Rounds 1
- Last Round Series A β $18.51M
- First Round $18.51M
(Jul 2021)
- Investors Count 1
All 1 funding rounds of Pilot gene technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | $18.51M | Series A | β | Share Capital | β |
1 investors in total: 1 institutional.
Investors in Pilot gene technology
Pilot gene technology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Share Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A venture capital firm based in Shenzhen, China, is operated. | – | sharecapital.cn | Shenzhen, China |
Investor details for Pilot gene technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pilot gene technology
2 dated milestones of Pilot gene technology across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Pilot gene technology is founded.
- Funding First funding round of $18.5M.
Web traffic of Pilot gene technology
Websites that share an audience with Pilot gene technology (pilotgene.com).
Websites whose visitors overlap most with Pilot gene technology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| coyotebio.com | 100% | 1.5K | #9,574,779 | View details |
Similar companies to Pilot gene technology
10 companies that operate in the same segment as Pilot gene technology (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pilot gene technology
Pilot gene technology was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Pilot gene technology is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Pilot gene technology is a funded company, having raised a total of $18.51M across 1 funding round to date. The company's 1st funding round was a Series A of $18.51M, raised on Jul 2021.
Pilot Gene Technology was established in 2017 and is based in Hangzhou, China. Focus is placed on research and development, production, and supply within the biotechnology sector, specifically digital PCR technologies. Operations involve creating tools for precise genetic quantification and analysis. Products are distributed to support applications in molecular diagnostics and research, with activities centered in the Asia-Pacific region.
Pilot gene technology offers Digital PCR System and PCR Detection Kits.
Pilot gene technology has 1 investor. Key investors include Share Capital.
Pilot gene technology operates through ,.